Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thiol-containing bacterial proteins comprise a diverse group of bacterial proteins characterized by the presence of cysteine residues with reactive thiol (-SH) groups. These thiol groups enable functional versatility, including participation in redox reactions, formation and reshuffling of disulfide bonds crucial for protein folding and function, and dynamic regulation via post-translational modifications such as S-glutathionylation and S-nitrosylation[1][2][4][5]. Certain subgroups are especially significant: - **Thioester-containing domains (TEDs):** Present in some Gram-positive bacterial surface proteins, TEDs covalently link bacteria to host proteins, contributing to infection and colonization. Disruption of these domains can potentially inhibit bacterial attachment and serve as an anti-infective strategy[3]. - **Thiol-activated cytolysins:** These form transmembrane pores in host cells upon being activated by thiols, playing a key role in bacterial virulence[6]. Thiol chemistry is critical for oxidative folding in the bacterial periplasm, orchestrated by enzymes such as DsbA and DsbC, which introduce and rearrange disulfide bonds in bacterial proteins[2]. Misregulation of thiol-containing proteins can lead to pathogenic protein misfolding or impaired host defense. Targeting bacterial thiol chemistry or thioester-dependent interactions represents a promising but challenging therapeutic strategy due to the ubiquitous and essential nature of thiols in both host and pathogen systems[1][5]. **Note:** This is a heterogeneous, functional, rather than single structural protein family. The query "Thiol-containing bacterial proteins" is too broad to serve as a unique canonical drug target entity. For structured records, it is recommended to specify the particular thiol-containing protein or functional subclass (e.g., "Thiol-activated cytolysin", "DsbA oxidoreductase", "Thioester-containing adhesin") for clearer mechanistic and therapeutic annotation.
Redox modification of thiol groups (disulfide bond formation/breakage) Inhibition or modification of thiol groups Interference with bacterial adhesion (for thioester proteins)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thiol-containing bacterial protein.